Status:
COMPLETED
MI-based PrEP Intervention
Lead Sponsor:
The Miriam Hospital
Conditions:
PrEP Uptake
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States. Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventin...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Assigned male at birth and currently identify as male
- Score at least 10 on the HIV Incident Risk Index for MSM
- HIV-negative based on results of antibody test
- English- or Spanish-speaking
- Have access to a working phone
- Have not taken PrEP
Exclusion
- Have previously taken PrEP
- Symptoms of acute HIV infection at baseline
- HIV positive
- A clinical contraindication to PrEP (e.g., renal dysfunction)
- Non-English or non-Spanish speaking
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03313765
Start Date
January 10 2019
End Date
April 30 2020
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Miriam Hospital
Providence, Rhode Island, United States, 02906